Literature DB >> 21051868

Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type.

Marc Ittah1, Corinne Miceli-Richard, Pierre Lebon, Coralie Pallier, Christine Lepajolec, Xavier Mariette.   

Abstract

B cell-activating factor of the TNF family (BAFF) plays a key role in promoting B lymphocyte activation and survival. We previously showed in primary Sjögren's syndrome that salivary gland epithelial cells (SGECs), the resident targeted cells of autoimmunity in this disease, can produce BAFF after infection with a double-stranded RNA (dsRNA) virus by a protein kinase RNA (PKR)-dependent mechanism. This study aimed to assess the effect of different viruses on various cell types - SGECs but also dendritic cells (DCs) and monocytes - in the induction of BAFF. BAFF induction was observed after Sendai virus infection of monocytes and SGECs, as well as poly(I:C) stimulation of DCs. However, PKR inhibition by 2-aminopurine failed to reduce BAFF expression in these infected or stimulated cells. Conversely, in Sendai virus-infected monocytes, blocking type 1 interferon (IFN) receptor by anti-IFNAR1 antibody strongly inhibited BAFF expression. These results provide additional data suggesting that both dsRNA virus stimulation of DCs and single-stranded RNA virus infection of SGECs or monocytes can induce BAFF expression, but through a PKR-independent mechanism for these 3 cell types and a type 1 IFN-dependent mechanism in monocytes and SGECs. Thus, BAFF induction by viral infection is a general phenomenon, but the types of viruses and mechanisms of the induction depend on the cell type.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051868     DOI: 10.1159/000321194

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  9 in total

Review 1.  Advances in understanding the pathogenesis of primary Sjögren's syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2013-07-16       Impact factor: 20.543

2.  B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.

Authors:  G Lake-Bakaar; I Jacobson; A Talal
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

3.  Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.

Authors:  Cuiling Yang; Na Li; Yawen Wang; Pingping Zhang; Qianqian Zhu; Fang Li; Qunying Han; Yi Lv; Ling Yu; Ping Wei; Zhengwen Liu
Journal:  J Interferon Cytokine Res       Date:  2014-05-08       Impact factor: 2.607

Review 4.  B cells in the pathogenesis of primary Sjögren syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

5.  Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.

Authors:  Petraleigh Pantoja; Erick X Pérez-Guzmán; Idia V Rodríguez; Laura J White; Olga González; Crisanta Serrano; Luis Giavedoni; Vida Hodara; Lorna Cruz; Teresa Arana; Melween I Martínez; Mariah A Hassert; James D Brien; Amelia K Pinto; Aravinda de Silva; Carlos A Sariol
Journal:  Nat Commun       Date:  2017-06-23       Impact factor: 14.919

Review 6.  Considerations for Novel COVID-19 Mucosal Vaccine Development.

Authors:  Wael Alturaiki
Journal:  Vaccines (Basel)       Date:  2022-07-23

Review 7.  Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.

Authors:  Olivier Garraud; Gwenoline Borhis; Gamal Badr; Séverine Degrelle; Bruno Pozzetto; Fabrice Cognasse; Yolande Richard
Journal:  BMC Immunol       Date:  2012-11-29       Impact factor: 3.615

8.  Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.

Authors:  Kavitha Kothur; Louise Wienholt; Shekeeb S Mohammad; Esther M Tantsis; Sekhar Pillai; Philip N Britton; Cheryl A Jones; Rajeshwar R Angiti; Elizabeth H Barnes; Timothy Schlub; Sushil Bandodkar; Fabienne Brilot; Russell C Dale
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

Review 9.  The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.

Authors:  Fabien B Vincent; Damien Saulep-Easton; William A Figgett; Kirsten A Fairfax; Fabienne Mackay
Journal:  Cytokine Growth Factor Rev       Date:  2013-05-15       Impact factor: 7.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.